NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $14.35 -0.36 (-2.45%) Closing price 09/17/2026 03:59 PM EasternExtended Trading$14.34 -0.01 (-0.07%) As of 07:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About USANA Health Sciences Stock (NYSE:USNA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$14.31▼$15.0050-Day Range$12.79▼$23.2252-Week Range$12.57▼$30.92Volume164,377 shsAverage Volume200,313 shsMarket Capitalization$265.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview USANA Health Sciences, Inc. develops and sells nutritional supplements, healthy foods and personal-care products. Its offerings include vitamin and mineral supplements, meal-replacement products, protein and nutrition products, and skincare and personal-care items marketed under the USANA brand. Founded in 1992 by immunologist Myron Wentz, the company uses a direct-selling business model. Products are distributed through independent associates, who market and sell USANA offerings directly to consumers and may build networks of other distributors. The company also provides products through its online shopping platforms in markets where it operates. USANA serves customers across a range of markets in the Asia-Pacific region, the Americas and Europe. Its products are manufactured and distributed in accordance with applicable regulatory requirements in the jurisdictions where they are sold, with the company emphasizing health, wellness and personal-care solutions.AI Generated. May Contain Errors. Read More USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreUSNA MarketRank™: USANA Health Sciences scored higher than 33% of companies evaluated by MarketBeat, and ranked 138th out of 174 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingSell Consensus RatingUSANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 2 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth132.89% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 132.89% in the coming year, from $0.76 to $1.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is -11.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is -11.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.61. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about USANA Health Sciences' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.52% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.13, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 14.59%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest1 people have searched for USNA on MarketBeat in the last 30 days. MarketBeat Follows2 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders0.82% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. USNA Stock News HeadlinesProtein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of FiberSeptember 3, 2026 | prnewswire.comUSANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then ActSeptember 1, 2026 | prnewswire.comThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.September 18 at 1:00 AM | Chaikin Analytics (Ad)USANA Health Sciences : USNAAugust 26, 2026 | 247wallst.comUSANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink MixAugust 17, 2026 | prnewswire.comUSANA Health Sciences Trims Outlook Amid Brand HeadwindsAugust 14, 2026 | theglobeandmail.com5 must-read analyst questions from USANA’s Q2 earnings callAugust 11, 2026 | msn.comWhy Usana Health Sciences Stock Plummeted This WeekAugust 9, 2026 | fool.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $19.61 at the beginning of 2026. Since then, USNA shares have decreased by 26.8% and is now trading at $14.35. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.50. The firm earned $223.27 million during the quarter, compared to the consensus estimate of $235 million. USANA Health Sciences had a positive trailing twelve-month return on equity of 3.41% and a negative net margin of 2.43%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? Top institutional shareholders of USANA Health Sciences include BlackRock Inc. (8.42%), Pzena Investment Management LLC (6.53%), Nantahala Capital Management LLC (4.39%) and Algert Global LLC (0.71%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX). Company Calendar Last Earnings8/04/2026Today9/18/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 USNA's financial health is in the Red zone, according to TradeSmith. USNA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,570Year Founded1992Profitability EPS (Trailing Twelve Months)($1.21) Trailing P/E RatioN/A Forward P/E Ratio18.88 P/E Growth1.61Net Income$10.76 million Net Margins-2.43% Pretax Margin0.28% Return on Equity3.41% Return on Assets2.50% Debt Debt-to-Equity RatioN/A Current Ratio2.66 Quick Ratio1.84 Sales & Book Value Annual Sales$913.36 million Price / Sales0.29 Cash Flow$4.03 per share Price / Cash Flow3.56 Book Value$29.16 per share Price / Book0.49Miscellaneous Outstanding Shares18,477,000Free Float18,325,000Market Cap$265.14 million OptionableOptionable Beta0.68 Social Links 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:USNA) was last updated on 9/18/2026 by MarketBeat.com Staff. From Our PartnersGold Miners Post Record Cash Flow Even as Prices Pull BackThe four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...Golden Portfolio | SponsoredIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | Sponsored$747 million in one quarter - with a 60% cash-flow targetThe company posted $747 million in net income last quarter and plans to return at least 60% of 2026 free cash ...Monument Traders Alliance | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.